RELMADA THERAPEUTICS INC filings

SEC filings by RELMADA THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-03-06PERCEPTIVE ADVISORS LLCRELMADA THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2024-02-14RTW INVESTMENTS, LPRELMADA THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPRELMADA THERAPEUTICS, INC.2,044,5076.8%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCRELMADA THERAPEUTICS, INC.1,310,8054.4%EDGAR
SC 13G/A2023-07-07BlackRock Inc.RELMADA THERAPEUTICS, INC.605,2542.0%EDGAR
SC 13G/A2023-02-14Point72 Asset Management, L.P.RELMADA THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2023-02-14RTW INVESTMENTS, LPRELMADA THERAPEUTICS, INC.2,067,8246.9%EDGAR
SC 13G/A2023-02-14BIOTECHNOLOGY VALUE FUND L PRELMADA THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2023-02-14CITADEL ADVISORS LLCRELMADA THERAPEUTICS, INC.-0.1%EDGAR
SC 13G/A2023-02-14RA CAPITAL MANAGEMENT, L.P.RELMADA THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2023-02-14Deep Track Capital, LPRELMADA THERAPEUTICS, INC.2,837,8189.4%EDGAR
SC 13G2023-02-09VANGUARD GROUP INCRELMADA THERAPEUTICS, INC.1,516,9805.0%EDGAR
SC 13G/A2023-02-01BlackRock Inc.RELMADA THERAPEUTICS, INC.1,863,1426.2%EDGAR
SC 13G2022-12-20KOTLER KEVINRELMADA THERAPEUTICS, INC.1,899,9306.3%EDGAR
SC 13G2022-10-21Deep Track Capital, LPRELMADA THERAPEUTICS, INC.2,481,0008.2%EDGAR
SC 13G2022-10-17Point72 Asset Management, L.P.RELMADA THERAPEUTICS, INC.2,081,3007.3%EDGAR
SC 13G2022-10-17CITADEL ADVISORS LLCRELMADA THERAPEUTICS, INC.-1.6%EDGAR
SC 13G2022-09-23PERCEPTIVE ADVISORS LLCRELMADA THERAPEUTICS, INC.2,099,9527.0%EDGAR
SC 13G/A2022-02-14RTW INVESTMENTS, LPRELMADA THERAPEUTICS, INC.2,186,3247.9%EDGAR
SC 13G2022-02-14Venrock Healthcare Capital Partners II, L.P.RELMADA THERAPEUTICS, INC.2,270,0728.2%EDGAR